首页> International journal of cancer> Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer.

Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Sophie C,Hagenaars

第一单位： Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.

作者： Sophie C,Hagenaars ^[1] ; Stefanie,de Groot ^[2] ; Danielle,Cohen ^[3] ; Tim J A,Dekker ^[4] ; Ayoub,Charehbili ^[4] ; Elma,Meershoek-Klein Kranenbarg ^[1] ; Marjolijn,Duijm-de Carpentier ^[1] ; Hanno,Pijl ^[5] ; Hein,Putter ^[6] ; Rob A E M,Tollenaar ^[1] ; Judith R,Kroep ^[2] ; Wilma E,Mesker ^[1] ; Dutch Breast Cancer Research Group (BOOG)

作者单位： Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. ^[1] Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. ^[2] Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. ^[3] Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.;Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. ^[4] Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands. ^[5] Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands. ^[6]

关键词 Miller-Payne breast cancer neoadjuvant pathological response tumor-stroma ratio